Search Result "Parkinsonian appearing"
Application of Chemoinformatic Tools for the Design of Novel Molecules as anti-Parkinsonian Agents
Journal: Current Signal Transduction Therapy
Volume: 13 Issue: 2 Year: 2018 Page: 119-128
Author(s): Ashis Nandy,Indrani Adhikari
The “Parkinsonian Heart”: From Novel Vistas to Advanced Therapeutic Approaches in Parkinsons Disease
Journal: Current Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2007 Page: 2421-2428
Author(s): Francesco Fornai, Riccardo Ruffoli, Paola Soldani, Stefano Ruggieri, Antonio Paparelli
Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Journal: Current Drug Therapy
Volume: 10 Issue: 2 Year: 2015 Page: 66-81
Author(s): Felix-Martin Werner,Rafael Coveñas
The Function of Tyrosine Hydroxylase in the Normal and Parkinsonian Brain
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11 Issue: 4 Year: 2012 Page: 381-386
Author(s): Christopher Tolleson,Daniel Claassen
Association Between Atrophy of the Caudate Nuclei, Global Brain Atrophy, Cerebral Small Vessel Disease and Mild Parkinsonian Signs in Neurologically and Cognitively Healthy Subjects Aged 45-84 Years: A Crosssectional Study
Journal: Current Alzheimer Research
Volume: 15 Issue: 11 Year: 2018 Page: 1013-1026
Author(s): Cecilia Camarda,Paola Torelli,Carmela Pipia,Iacopo Battaglini,Delia Azzarello,Rosamaria Rosano,Giusi Daniela Ventimiglia,Gianluca Sottile,Giovanna Cilluffo,Rosolino Camarda
Targeting Nicotinic Receptors for Parkinsons Disease Therapy
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10 Issue: 6 Year: 2011 Page: 651-658
Author(s): Maryka Quik, Tanuja Bordia, Luping Huang, Xiomara Perez
Evolution of Antipsychotic Intervention in the Schizophrenic Psychosis
Journal: Current Drug Targets
Volume: 7 Issue: 9 Year: 2006 Page: 1205-1215
Author(s): David L. Garver
Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration
Journal: Current Neuropharmacology
Volume: 8 Issue: 1 Year: 2010 Page: 62-68
Author(s): Anna L. Bartels, Klaus L. Leenders
L-DOPA and Serotonergic Neurons: Functional Implication and Therapeutic Perspectives in Parkinsons Disease
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 11 Issue: 4 Year: 2011 Page: 305-320
Author(s): Sylvia Navailles, Manolo Carta, Martin Guthrie, Philippe De Deurwaerdere
Vascular Dementia: Atherosclerosis, Cognition and Alzheimers Disease
Journal: Current Alzheimer Research
Volume: 8 Issue: 4 Year: 2011 Page: 341-344
Author(s): R. J. OBrien